Latest filing published 25 Aug 2026 for Lyell Immunopharma, Inc., €13k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Stephen J. Hill: trading record in brief
Stephen J. Hill appears in our data through filings on Lyell Immunopharma, Inc. shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 9 February 2024 to 21 August 2026.
Every open-market trade on record is a sale: 8 sales worth €53k. Besides market trades, the filings include 4 share grants. 2026 to date brings no purchases and 4 sales.
The newest entry dates from 25 August 2026: an open-market sale of €13k, in Lyell Immunopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen J. Hill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 989 shares@ US$15.54Common StockSEC:0001866154-26-000006:0
- 89 shares@ US$14.340.0004% mcap4.0% of flowCommon StockSEC:0001866154-26-000004:0
- 1,236 shares@ US$23.3991.9% of flowCommon StockSEC:0001866154-26-000002:0
- 4,000 shares0Common StockSEC:0001866154-26-000001:0
- 95 shares@ US$16.1261.7% of flowCommon StockSEC:0001866154-25-000006:0
- 8,000 shares0Common StockSEC:0001415889-25-022746:0
- 91 shares@ US$10.526100.0% of flowCommon StockSEC:0001415889-25-021693:0
- 112,500 shares0Common StockSEC:0001415889-25-005760:0
- 40,000 shares0Common StockSEC:0001209191-24-003274:0
9 of 9 declarations
